ADAM BIED: Open Payments
NPI 1104185586 · MATTAPAN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 15 payments from 5 companies in 2025. Trend: 2023 $13,931 · 2024 $13,855 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 6 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $129 |
| Gilead Sciences, Inc. | 1 | $124 |
| Supernus Pharmaceuticals, Inc. | 3 | $65 |
| Vertical Pharmaceuticals, LLC | 1 | $24 |
Products named: BRIXADI, CAPLYTA, Yeztugo, Qelbree, Relexxii.
Industry payments across MA — which companies pay providers there.
